| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/29/2004 | CN1532182A Preparation of piper laetispicum effective part and its use in medical therapy and health field |
| 09/29/2004 | CN1531969A Brain protein hydrolysate freeze-drying powder injection and its preparing method |
| 09/29/2004 | CN1531961A Chinese medine for treating paraplegia |
| 09/29/2004 | CN1531954A Medicine for treating depression and its preparing method |
| 09/29/2004 | CN1531951A Chinese medicine compound preparation for nourishing the heart to calm the mind and preparing method |
| 09/29/2004 | CN1531945A Formula and prepn process of danlong refreshment medicine |
| 09/29/2004 | CN1531928A Panaxitriol saponin preparation with biological activity and use |
| 09/29/2004 | CN1531927A Panaxadiol saponin preparation with biological activity and use |
| 09/29/2004 | CN1531924A Use of isovaleric acid derivatives CNS inhibitors in preparing medicine for curing headache |
| 09/29/2004 | CN1168728C Pyrrolo-isoquinoline and tetrahydropyrrolko-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 09/29/2004 | CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 09/29/2004 | CN1168458C Chinese medicine for treating intractable insomnia and its preparation method |
| 09/29/2004 | CN1168443C Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors |
| 09/29/2004 | CN1168442C Methods and compsns. for stimulating neurite growth |
| 09/29/2004 | CN1168441C Use of dexmedetomidine for ICU sedation |
| 09/29/2004 | CN1168440C Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 09/28/2004 | US6797806 Multimeric proteins;for diagnosis and therapy of disorders involving complement activity (globulins) and various inflammatory and immune disorders |
| 09/28/2004 | US6797732 Oral solid for treating parkinson's disease where a subtantial portion of carbidopa is separate from entacapone and levodopa |
| 09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 09/28/2004 | US6797722 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases |
| 09/28/2004 | US6797718 Ether substituted imidazopyridines |
| 09/28/2004 | US6797712 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 09/28/2004 | US6797699 Exemplified by n'-l-arginylspermidine |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797285 Leaves of Cajanus Cajan(L.) Millsp and extract, formulation and uses thereof |
| 09/28/2004 | US6797284 Plant extracts and amino acids, that can be used to reduce tobacco smoke addiction |
| 09/28/2004 | US6797264 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 09/28/2004 | US6797263 Compositions and methods for achieving immune suppression |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2191088C Copolymer-1 improvements in compositions of copolymers |
| 09/28/2004 | CA2128312C Use of n-(pyridinyl)-1h-indol-1-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004081010A1 Compounds having activity at 5ht2c receptor and uses thereof |
| 09/23/2004 | WO2004081007A1 Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 09/23/2004 | WO2004081001A1 Novel 2-pyridinecarboxamide derivatives |
| 09/23/2004 | WO2004080998A1 Imidazol-4-yl-ethynyl-pyridine derivatives |
| 09/23/2004 | WO2004080986A1 Phenyl sulfone derivatives and their use in the treatment of cns disorders |
| 09/23/2004 | WO2004080983A1 Novel lactams and uses thereof |
| 09/23/2004 | WO2004080981A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
| 09/23/2004 | WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 09/23/2004 | WO2004080965A1 Neuropeptide ff receptor antagonist |
| 09/23/2004 | WO2004080950A1 Substituted aniline derivatives |
| 09/23/2004 | WO2004080459A1 Method for treating mild cognitive impairment and for preventing or delaying alzheimer’s disease |
| 09/23/2004 | WO2004080454A1 Composition comprising 5-hydroxytryptophan for reducing or alleviating the effects of nicotine withdrawal and use thereof |
| 09/23/2004 | WO2004080448A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 09/23/2004 | WO2004080436A1 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 09/23/2004 | WO2004080419A2 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | WO2004080382A2 Novel compositions containing fentanyl |
| 09/23/2004 | WO2004064721A3 A pyrazolopyrimidine compound and a process for preparing the same |
| 09/23/2004 | WO2004058353A3 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 09/23/2004 | WO2004052350A3 Method of treating movement disorders using barbituric acid derivatives |
| 09/23/2004 | WO2004050120A3 Treatment of prion-induced diseases by administration fo anti-prion antibodies |
| 09/23/2004 | WO2004041258A3 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 09/23/2004 | WO2004014850A3 Substituted aminopyrimidines as neurokinin antagonists |
| 09/23/2004 | WO2003105561A3 Method and devices for diagnosing and treating choroid plexus failure |
| 09/23/2004 | WO2003072552A8 Method for preparing benzisoxazole methane sulfonyl chloride and its amidation to form zonisamide |
| 09/23/2004 | WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 09/23/2004 | US20040186320 Antioxidant nitroxides and nitrones as therapeutic agents |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186295 G protein-coupled receptors activators such as 2-[2-(3-chlorophenyl)-2H-tetrazol-5-yl]pyridine, used as analgesics, anxiolytic, antidepressants, and for prophylaxis of psychological disorders |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186163 Novel combination |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186147 Sulphonamides for control of beta-amyloid production |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186144 Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals |
| 09/23/2004 | US20040186136 E.g., mono-, poly- or perdeuteriated tolperisone and eperisone; appreciably better pharmacokinetic and/or pharmacodynamic properties than the undeuterated compounds; muscular disorders; muscle relaxants (skeletal); antispasmodic agents; vasodilation |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186123 such as 2[(Benzyloxy)methyl]-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinoline; serotonin receptor antagonists for treatment of depression, obsessive compulsive disorders, panic disorder, generalized anxiety disorder, social anxiety disorders, sexual dysfunction, and eating disorders |
| 09/23/2004 | US20040186121 Tamper-resistant oral opioid agonist formulations |
| 09/23/2004 | US20040186120 for treatment of focal distonia, tremors, and parkinson's disease |
| 09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 09/23/2004 | US20040186108 such as N-{2-[2-(4-1,2-Benzisothiazol-3-yl-piperazin-1-yl)-ethyl]-phenyl}-2-(2,5-dimethoxy-phenyl)-acetamide; antagonists of dopamine D2 receptors and of serotonin 2A (5HT2a) receptors; for treatment of depression and dementia/schizophrenia |
| 09/23/2004 | US20040186107 Diazabicyclic central nervous system active agents |
| 09/23/2004 | US20040186106 such as (S)-N-{{(1R, 2R)-2-{4-{[2-(4-Methyl-piperazin-1-yl)-benzimidazol-1-yl]methyl}-phenyl}-cyclohex-1-yl} carbonyl}-phenylglycinamide; for treatment of ischemic brain disorders |
| 09/23/2004 | US20040186104 Novel pyridinone and related heterocyclic derivatives |
| 09/23/2004 | US20040186100 X-ray diffraction patterning; for treatment of migraine, rheumatoid arthritis, asthma, bronchial hyperreactivity, allergic rhinitis, ocular inflammatory diseases, and oedema; for treating drug abuse |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186081 Naaladase inhibitors for treating opioid tolerance |
| 09/23/2004 | US20040186076 Pharmaceutical complex |
| 09/23/2004 | US20040186051 Apo-2 ligand variants and uses thereof |
| 09/23/2004 | US20040186048 Gene regulation therapy involving ferritin |
| 09/23/2004 | US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/23/2004 | US20040185533 Corticotropin-releasing factor2 receptors |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |